Ledger.Open graph →
SEC Form D · Amendment · filed July 15, 2016

Neurovance, Inc

Offering
$6.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (29)

Brigitte A. Smith · Melbourne VIC, Channel IslandsDirectorCampbell A. Murray · Cambridge, MADirectorWilliam T. Pappafotopoulos · Cambridge, MAExecAlbert L. Sokol · Boston, MAExecAnthony A. Mckinney · Cambridge, MAExec · DirectorTimothy J. Barberich · Concord, MADirectorDaniel A. Omstead · Boston, MADirectorGregg T. Beloff · Cambridge, MAExecJeffrey L. Bailey · Cambridge, MADirectorRoss A. Reife · Cambridge, MAExecPaul A. Weiss · Madison, WIDirectorRobert L. Riedl · Appleton, WIExecColin Carr · Lone Tree, COExecChris J. O'Reilly · Atlanta, GADirectorJeri P. Wechsler · Houston, TXExecJames W. Judson · Seattle, WAExecR. D. Newton · Plano, TXDirectorSusan Oh · Denver, CODirectorBrett D. Forman · Palm Beach, FLDirectorMichael A. Groneberg · MINNEAPOLIS, MNDirectorGeoff Huber · MINNEAPOLIS, MNExec · DirectorTroy L. Beckett · Houston, TXExec · DirectorCharles J. Neverdowski · Houston, TXExecAnna M. Lantz · Houston, TXDirectorPaul Stevenson · Smiths, BermudaDirectorCharles Thomas · Grand Cayman, Cayman IslandsDirectorDaniel Grugan · Wilmington, DEExecJohn Mcpheters · New York, NYDirectorRichard F. Blubaugh · Greenwood Village, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗